These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1378882)

  • 1. Murine monoclonal antibodies directed against the transmembrane protein gp41 of human immunodeficiency virus type 1 enhance its infectivity.
    Niedrig M; Bröker M; Walter G; Stüber W; Harthus HP; Mehdi S; Gelderblom HR; Pauli G
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():951-4. PubMed ID: 1378882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of viral replication by monoclonal antibodies directed against human immunodeficiency virus gp120.
    Niedrig M; Harthus HP; Hinkula J; Bröker M; Bickhard H; Pauli G; Gelderblom HR; Wahren B
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2451-5. PubMed ID: 1383412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.
    Xu JY; Gorny MK; Palker T; Karwowska S; Zolla-Pazner S
    J Virol; 1991 Sep; 65(9):4832-8. PubMed ID: 1714520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of monoclonal antibodies to human immunodeficiency virus type 1 gp41 by HIV-1 polypeptides expressed in Escherichia coli.
    Larcher C; Bröker M; Huemer HP; Sölder B; Schulz TF; Hofbauer JM; Wachter H; Dierich MP
    FEMS Microbiol Immunol; 1990 Sep; 2(2):103-10. PubMed ID: 1701654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera.
    Vella C; Ferguson M; Dunn G; Meloen R; Langedijk H; Evans D; Minor PD
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2603-7. PubMed ID: 7506299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of anti-gp41 core structure antibodies, which compete with sera of HIV-1-infected patients.
    Usami O; Xiao P; Ling H; Liu Y; Nakasone T; Hattori T
    Microbes Infect; 2005 Apr; 7(4):650-7. PubMed ID: 15823513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunogenetic properties of peptides mimicking a human immunodeficiency virus gp41 (HIV-1) epitope recognized by virus-neutralizing antibody 2F5].
    Tumanova OIu; Kuvshinov VN; Orlovskaia IA; Proniaeva TR; Pokrovskiĭ AG; Il'ichev AA; Sandakhchiev LS
    Mol Biol (Mosk); 2003; 37(3):556-60. PubMed ID: 12815965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1.
    Veronese FD; Rahman R; Kalyanaraman VS; Pal R; Lusso P; Tritch R; Petteway S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1989 Oct; 5(5):479-86. PubMed ID: 2480151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products.
    Pollock BJ; McKenzie AS; Kemp BE; McPhee DA; D'Apice AJ
    Clin Exp Immunol; 1989 Dec; 78(3):323-8. PubMed ID: 2482145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus.
    Banapour B; Rosenthal K; Rabin L; Sharma V; Young L; Fernandez J; Engleman E; McGrath M; Reyes G; Lifson J
    J Immunol; 1987 Dec; 139(12):4027-33. PubMed ID: 2447158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive study of monoclonal antibodies against the HIV-1 Gp41 core structure.
    Usami O; Xiao P; Ling H; Hattori T
    Microbiol Immunol; 2006; 50(2):131-4. PubMed ID: 16490931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
    Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
    Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.
    Robinson WE; Kawamura T; Gorny MK; Lake D; Xu JY; Matsumoto Y; Sugano T; Masuho Y; Mitchell WM; Hersh E
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3185-9. PubMed ID: 2326277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELDKWA-epitope-specific monoclonal antibodies inhibit HIV env-mediated syncytium formation.
    Zhang G; Chen YH
    Immunobiology; 2003; 207(4):259-64. PubMed ID: 12952348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein.
    Earl PL; Broder CC; Doms RW; Moss B
    J Virol; 1997 Apr; 71(4):2674-84. PubMed ID: 9060620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1.
    Niedrig M; Harthus HP; Bröker M; Meloen R; Gelderblom H; Pauli G
    Hybridoma; 1993 Aug; 12(4):431-9. PubMed ID: 7503941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential IgG subclass responses to epitopes in transmembrane protein of HIV-1.
    Klasse PJ; Blomberg J; Pipkorn R
    Viral Immunol; 1990; 3(2):89-98. PubMed ID: 1694431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5].
    Tumanova OIu; Kuvshinov VN; Azaev MSh; Masharskiĭ AE; Klimov NA; Kozlov AP; Il'ichev AA; Sandakhchiev LS
    Mol Biol (Mosk); 2001; 35(1):146-51. PubMed ID: 11234374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates.
    Cotropia J; Ugen KE; Kliks S; Broliden K; Broliden PA; Hoxie JA; Srikantan V; Williams WV; Weiner DB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):221-32. PubMed ID: 8673526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.